Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses
Open Access
- 19 April 2019
- journal article
- review article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 15 (6) , 1317-1325
Abstract
The enteropathogen, Shigella, is highly virulent and remarkably adjusted to the intestinal environment of its almost exclusive human host. Key for Shigella pathogenicity is the injection of virulence effectors into the host cell via its type three secretion system (T3SS), initiating disease onset and progression by the vast diversity of the secreted T3SS effectors and their respective cellular targets. The multifaceted modulation of host signaling pathways exerted by Shigella T3SS effectors, which include the subversion of host innate immune defenses and the promotion of intracellular bacterial survival and dissemination, have been extensively reviewed in the recent past. This review focuses on the human species specificity of Shigella by discussing some possible evasion mechanisms towards the human, but not non-human or rodent gut innate defense barrier, leading to the lack of a relevant animal infection model. In addition, subversion mechanisms of the adaptive immune response are highlighted summarizing research advances of the recent years. In particular, the new paradigm of Shigella pathogenicity constituted of invasion-independent T3SS effector-mediated targeting of activated, human lymphocytes is discussed. Along with consequences on vaccine development, these findings offer new directions for future research endeavors towards a better understanding of immunity to Shigella infection.Keywords
This publication has 126 references indexed in Scilit:
- Shigella impairs T lymphocyte dynamics in vivoProceedings of the National Academy of Sciences, 2013
- Tolerogenic therapies in transplantationFrontiers in Immunology, 2012
- Up-Regulation of MUC2 and IL-1β Expression in Human Colonic Epithelial Cells by Shigella and Its Interaction with MucinsPLOS ONE, 2011
- Proteomics and Pathway Analyses of the Milk Fat Globule in Sheep Naturally Infected by Mycoplasma agalactiae Provide Indications of the In Vivo Response of the Mammary Epithelium to Bacterial InfectionInfection and Immunity, 2011
- Antigen-Specific CD8 + T Cells Fail To Respond to Shigella flexneriInfection and Immunity, 2011
- Mucin dynamics and enteric pathogensNature Reviews Microbiology, 2011
- The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectorsMolecular Microbiology, 2010
- Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogensImmunology, 2009
- Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expressionJournal of Experimental Medicine, 2008
- Structural Insights into the Assembly of the Type III Secretion Needle ComplexScience, 2004